UNCY Unicycive Therapeutics, Inc.
$3.61▲ +0.84%
Healthcare
Other
After hours
$3.61▲ +0.00%
Oct 27, 4:00 PM ET
Volume 1.34M
Avg Volume (10D) 1.21M
Key Metrics & Fundamentals
Market Cap
$98.89M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.35 - 8.74
% vs 50 MA
-22.29%
% vs 200 MA
-41.19%
RSI-14
35.1
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.97
Free Cash Flow
-$7.60M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$9.55M
COGS
–
Operating Exp
$10.14M
Operating Income
-$10.14M
EBIT
-$10.14M
Pretax Income
-$1.72M
Net Income
-$1.72M
EPS (Diluted)
-0.06
Price & Volume History
Loading chart…
Recent News
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission, PDUFA Date of March 25, 2027
InvestorsHub · Oct 21, 2026 5:35 PM ET
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
GlobeNewswire · Oct 21, 2026 7:05 AM ET
Unicycive Therapeutics (UNCY) Loses 21.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Oct 13, 2026 8:35 AM ET
Unicycive Therapeutics Appoints Meredith Manning to Board of Directors
GlobeNewswire · Oct 1, 2026 7:05 AM ET
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
GlobeNewswire · Sep 29, 2026 7:05 AM ET
Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 1, 2026 7:05 AM ET
B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating
MT Newswires · Aug 13, 2026 8:21 AM ET
Unicycive Therapeutics shares rise after second-quarter loss beats forecasts
InvestorsHub · Aug 12, 2026 8:00 AM ET
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 12, 2026 7:19 AM ET
Hyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight
PR Newswire · Aug 5, 2026 10:31 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See UNCY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.